Pharmanutra S.p.A. (BIT:PHN)
Italy · Delayed Price · Currency is EUR 89.40
-0.60 (-0.67%)
Jun 17, 2026, 5:35 PM CET
Pharmanutra Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 21.02 | 20 | 16.61 | 12.83 | 15.05 | 13.77 |
Depreciation & Amortization | 3.21 | 3.2 | 3.51 | 2.42 | 1.15 | 1.01 |
Other Amortization | 0.22 | 0.22 | - | - | - | - |
Provision & Write-off of Bad Debts | 0.23 | 0.16 | 0.14 | 0.21 | 0.17 | 0.15 |
Other Operating Activities | 1.48 | 1.45 | 1.25 | 1.41 | 0.81 | 1.26 |
Change in Accounts Receivable | -4.72 | -2.87 | -2.98 | 2.22 | -5.15 | -1.77 |
Change in Inventory | -0.05 | -1.91 | 1.22 | -2.91 | -2.4 | -0.97 |
Change in Accounts Payable | 0.74 | 4.1 | 1.43 | -0.78 | 7.14 | 2.58 |
Change in Income Taxes | -0.51 | -1.3 | 0.02 | 2.55 | -3.04 | 3.59 |
Change in Other Net Operating Assets | -2.1 | -3.39 | -0.72 | -5.87 | 3.74 | 0.81 |
Operating Cash Flow | 19.45 | 19.56 | 20.42 | 12.09 | 17.47 | 20.41 |
Operating Cash Flow Growth | -21.48% | -4.22% | 68.91% | -30.77% | -14.44% | 73.02% |
Capital Expenditures | -3.43 | -3.13 | -4.25 | -13.25 | -26.16 | -4.99 |
Sale of Property, Plant & Equipment | 0.08 | 0.02 | 0.66 | 0.55 | 0.27 | 0.08 |
Investment in Securities | - | - | - | - | 0.25 | - |
Other Investing Activities | -1.91 | -0.25 | 1.38 | -2.01 | -1.08 | -0.64 |
Investing Cash Flow | -5.27 | -3.36 | -2.21 | -14.7 | -26.72 | -5.54 |
Long-Term Debt Issued | - | 2.56 | 0.62 | 10.99 | 15.41 | 5.41 |
Total Debt Issued | 1.8 | 2.56 | 0.62 | 10.99 | 15.41 | 5.41 |
Long-Term Debt Repaid | - | -6.32 | -6.11 | -0.7 | -4.04 | -0.72 |
Total Debt Repaid | -6.75 | -6.32 | -6.11 | -0.7 | -4.04 | -0.72 |
Net Debt Issued (Repaid) | -4.96 | -3.76 | -5.49 | 10.29 | 11.38 | 4.69 |
Repurchase of Common Stock | -1.08 | -1.33 | -0.55 | -1.65 | -2.36 | - |
Common Dividends Paid | -9.59 | -9.59 | -8.17 | -7.71 | -6.85 | -6.49 |
Other Financing Activities | -1.22 | 1.56 | -7.38 | -1.44 | -0.27 | -0.12 |
Financing Cash Flow | -16.85 | -13.12 | -21.6 | -0.52 | 1.89 | -1.92 |
Net Cash Flow | -2.67 | 3.08 | -3.39 | -3.13 | -7.36 | 12.95 |
Free Cash Flow | 16.02 | 16.43 | 16.17 | -1.16 | -8.69 | 15.43 |
Free Cash Flow Growth | -22.29% | 1.59% | - | - | - | 52.49% |
Free Cash Flow Margin | 11.53% | 12.43% | 13.92% | -1.15% | -10.46% | 22.64% |
Free Cash Flow Per Share | 1.68 | 1.71 | 1.68 | -0.12 | -0.90 | 1.59 |
Levered Free Cash Flow | 14.66 | 15.2 | 12.74 | 2.25 | -14.67 | 11.35 |
Unlevered Free Cash Flow | 15.03 | 15.61 | 13.4 | 2.75 | -14.63 | 11.36 |
Change in Working Capital | -6.64 | -5.37 | -1.03 | -4.78 | 0.29 | 4.23 |